SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-23-008854
Filing Date
2023-03-24
Accepted
2023-03-24 15:49:58
Documents
15
Period of Report
2023-03-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 42272
2 ex99-1.htm EX-99.1 13040
3 ex99-1_001.jpg GRAPHIC 15200
  Complete submission text file 0001493152-23-008854.txt   302221

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE biaf-20230324.xsd EX-101.SCH 3990
5 XBRL DEFINITION FILE biaf-20230324_def.xml EX-101.DEF 26626
6 XBRL LABEL FILE biaf-20230324_lab.xml EX-101.LAB 36673
7 XBRL PRESENTATION FILE biaf-20230324_pre.xml EX-101.PRE 25250
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 6209
Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

IRS No.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41463 | Film No.: 23759766
SIC: 8731 Services-Commercial Physical & Biological Research